The success of glaucoma therapy in diabetes mellitus and non-diabetes mellitus

Nur Shani Meida, Ahmad Ikliluddin, Yunani Setyandriana, Ilma Naafisa Anthrasita

Abstract

ABSTRACT

 

Glaucoma is a disease marked with damage to the optic nerve, chronic and can cause blindness. Glaucoma needs regular therapy to prevent blindness. This study was an observational study using a case-control approach. Data were analyzed using the Mann-Whitney test to determine the differences in blood sugar levels in the DM and non-DM groups and the Chi-Square test to determine differences in the success of glaucoma therapy in DM and non-DM patients. There were 66 samples of glaucoma patients in this study, consisting of 14 men (21.2%) and 52 women (78.8%). The mean age of the patients was 61.12 ± 9.17 years. The sample was divided into 2 groups, namely 34 DM patients (51.5%) and 32 non DM patients (48.5%). The Mann-Whitney test showed significant differences in blood sugar levels between the DM and non-DM groups (p <0.05). Blood sugar levels in the DM group were 202.59 ± 73.5 mg / dL and in the non-DM group was 106.19 ± 16.3 mg / dL. In conclusion, there is no difference in the success of glaucoma therapy in DM and non-DM patients.

 

Keywords             : glaucoma, glaucoma therapy, diabetes mellitus

Correspondence        :nurshani_meida@yahoo.com

Keywords

glaucoma; glaucoma therapy; diabetes mellitus

Full Text:

PDF

References

Agudo-Barriuso, M., Villegas-Pérez, M. P., De Imperial, J. M., & Vidal-Sanz, M. (2013). Anatomical and functional damage in experimental glaucoma. Current Opinion in Pharmacology, 13(1), 5–11. https://doi.org/10.1016/j.coph.2012.09.006

Baisakhiya, S., Garg, P., & Singh, S. (2017). Association between glycemic control and intraocular pressure in patients with Type II diabetes mellitus. National Journal of Physiology, Pharmacy and Pharmacology, 7(1), 43–46. https://doi.org/10.5455/njppp.2016.6.0718813072016

Benjamin Joana Galvao Maria MDavis Cordeiro Francesca. (2013). In vivo imaging of retinal ganglion cell apoptosis. Current Opinion in Pharmacology, Volume 13(1), 123–127. https://www.sciencedirect.com/science/article/abs/pii/S1471489212001579

Costa, L., Cunha, J. P., Amado, D., Pinto, L. A., & Ferreira, J. (2015). Diabetes mellitus as a risk factor in glaucoma’s physiopathology and surgical survival time: A literature review. Journal of Current Glaucoma Practice, 9(3), 81–85. https://doi.org/10.5005/jp-journals-10008-1190

Desai, A., Patel, D., Sapovadia, A., Mehta, P., & Brahmbhatt, J. (2018). A study of relation between primary open angle glaucoma and type II diabetes mellitus. International Journal of Research in Medical Sciences, 6(3), 997. https://doi.org/10.18203/2320-6012.ijrms20180629

Gauthier, A. C., & Liu, J. (2017). Epigenetics and Signaling Pathways in Glaucoma. BioMed Research International, 2017. https://doi.org/10.1155/2017/5712341

Kida, T., Oku, H., Horie, T., Matsuo, J., Kobayashi, T., Fukumoto, M., & Ikeda, T. (2015). Nadph oxidase-mediated ROS production determines insulin’s action on the retinal microvasculature. Investigative Ophthalmology and Visual Science, 56(11), 6754–6761. https://doi.org/10.1167/iovs.15-17534

Lavaju, P., Shah, S., Sharma, S., & Maskey, R. (2017). Diabetes Mellitus and the risk of Primary open angle glaucoma. Nepalese Journal of Ophthalmology, 9(1), 17–23. https://doi.org/10.3126/nepjoph.v9i1.17526

Paul Riordan-Eva, J. J. A. (2018). Vaughan & Asbury’s General Ophthalmology, 19th Edition (19th ed.). McGraw-Hill Education. https://accessmedicine.mhmedical.com/book.aspx?bookID=2186

Pimentel, L. G. M., Gracitelli, C. P. B., Da Silva, L. S. A. C., Souza, A. K. S., & Prata, T. S. (2015). Association between glucose levels and intraocular pressure: Pre- and postprandial analysis in diabetic and nondiabetic patients. Journal of Ophthalmology, 2015. https://doi.org/10.1155/2015/832058

Rizka, N., Mardalena, E., & Andriaty, S. N. (2020). Universitas Abulyatama Pengaruh Tingkat Kepatuhan Penderita Glaukoma Datang Kontrol ke Poli Mata RSUD Meuraxa Banda Aceh terhadap Keberhasilan Terapi. 2(1), 126–135.

Setiawan, B., & Suhartono, E. (2007). Peroksidasi Lipid dan Penyakit Terkait Stress Oksidatif. Majalah Kedokteran Indonesia, 57(1), 10–14.

Torres-Martínez, L. A., Lara-Huerta, S. F., Babayán-Mena, J. I., & Herrero-Herrera, S. (2016). Intraocular pressure control in patients with primary open angle glaucoma and diabetes mellitus. Archivos de La Sociedad Española de Oftalmología (English Edition), 91(3), 125–129. https://doi.org/10.1016/j.oftale.2016.02.003

Tripathi Shweta, S. M. (2020). Glaucoma and diabetes: A review. Indian Journal of Clinical and Experimental Ophthalmology, 4(3), 294–299. https://doi.org/10.18231/2395-1451.2018.0066

Vidal-Sanz M, Salinas-Navarro M, Nadal-Nicolásb Francisco M, Alarcón-Martínez LuisF Javier Valiente-Soriano, Jaime Miralles de Imperial, Marcelino Avilés-Trigueros, Marta Agudo-Barriuso, M. P. V.-P. (2012). Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Progress in Retinal and Eye Research, 31(1), 1–27. https://www.sciencedirect.com/science/article/pii/S1350946211000619?via%3Dihub

Wright, E., Scism-Bacon, J. L., & Glass, L. C. (2006). Oxidative stress in type 2 diabetes: The role of fasting and postprandial glycaemia. International Journal of Clinical Practice, 60(3), 308–314. https://doi.org/10.1111/j.1368-5031.2006.00825.x


DOI: http://dx.doi.org/10.30651/jqm.v6i1.7665